A Phase 3 Study Of HP802-247 For Leg Ulcers Fails To Meet Goal

October 13, 2014 8:15 AM

4 0

A Phase 3 Study Of HP802-247 For Leg Ulcers Fails To Meet Goal

Smith & Nephew Plc (SN.L,SNN: Quote) Monday said a Phase 3 study of HP802-247 in North America for leg ulcers treatment did not meet primary endpoint, and failed to achieve a statistically significant improvement in healing compared with placebo.

Olivier Bohuon, chief executive officer of the medical technology company said, "A thorough assessment is underway to determine why the preliminary results of the first Phase 3 study are inconsistent with the strongly positive Phase 2a/2b results."

Read more

To category page

Loading...